Literature DB >> 31330079

A new series of Schiff base derivatives bearing 1,2,3-triazole: Design, synthesis, molecular docking, and α-glucosidase inhibition.

Ensieh Nasli-Esfahani1, Maryam Mohammadi-Khanaposhtani2, Sepideh Rezaei3, Yaghoub Sarrafi4, Zeinab Sharafi5, Nasser Samadi6, Mohammad Ali Faramarzi6, Fatemeh Bandarian1, Haleh Hamedifar7, Bagher Larijani8, Mirhamed Hajimiri9, Mohammad Mahdavi8.   

Abstract

A series of new Schiff bases bearing 1,2,3-triazole 12a-o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug acarbose. The kinetic study on the most potent compound 12n showed that this compound acted as a competitive α-glucosidase inhibitor. The docking study revealed that the synthesized compounds interacted with the important residues in the active site of α-glucosidase.
© 2019 Deutsche Pharmazeutische Gesellschaft.

Entities:  

Keywords:  1,2,3-triazole; Schiff base; antidiabetic activity; molecular docking; α-glucosidase

Mesh:

Substances:

Year:  2019        PMID: 31330079     DOI: 10.1002/ardp.201900034

Source DB:  PubMed          Journal:  Arch Pharm (Weinheim)        ISSN: 0365-6233            Impact factor:   3.751


  3 in total

1.  Design, synthesis, and molecular docking studies of diphenylquinoxaline-6-carbohydrazide hybrids as potent α-glucosidase inhibitors.

Authors:  Keyvan Pedrood; Zahra Rezaei; Kimia Khavaninzadeh; Bagher Larijani; Aida Iraji; Samanesadat Hosseini; Somayeh Mojtabavi; Mehdi Dianatpour; Hossein Rastegar; Mohammad Ali Faramarzi; Haleh Hamedifar; Mir Hamed Hajimiri; Mohammad Mahdavi
Journal:  BMC Chem       Date:  2022-07-31

2.  Docking study, molecular dynamic, synthesis, anti-α-glucosidase assessment, and ADMET prediction of new benzimidazole-Schiff base derivatives.

Authors:  Homa Azizian; Keyvan Pedrood; Ali Moazzam; Yousef Valizadeh; Kimia Khavaninzadeh; Ali Zamani; Maryam Mohammadi-Khanaposhtani; Somayeh Mojtabavi; Mohammad Ali Faramarzi; Samanesadat Hosseini; Yaghoub Sarrafi; Hossein Adibi; Bagher Larijani; Hossein Rastegar; Mohammad Mahdavi
Journal:  Sci Rep       Date:  2022-09-01       Impact factor: 4.996

Review 3.  Triazole-Modified Peptidomimetics: An Opportunity for Drug Discovery and Development.

Authors:  Agnieszka Staśkiewicz; Patrycja Ledwoń; Paolo Rovero; Anna Maria Papini; Rafal Latajka
Journal:  Front Chem       Date:  2021-05-20       Impact factor: 5.221

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.